ACDM News Item

Recent News in Regulatory Landscape

Date: June 11, 2026

The ACDM Regulatory Considerations DMEG have kindly put together a short news piece detailing recent news across the regulatory landscape in Clinical Data Management.

Read their update here:

Exciting news in the regulatory space! ICH released ICH E6 R3 Annex 2 on June 3, 2026. According to the introduction Annex 2 supplements R3 and Annex 1 approach to applying risk proportionate approaches to trial design and conduct. Annex 2 expands on this with a focus on decentralized trials approaches, pragmatic elements and real-world data (RWD).

The ACDM DMEG on Regulatory Considerations is looking forward to reviewing Annex 2 and publishing a summary of the highlights that impact data management. But in the interim we wanted to share the document with you. You can access the document using the link below.

https://database.ich.org/sites/default/files/ICH_E6%28R3%29_Annex%202_Guideline_Step%204_2026_0603_0.pdf

The Regulatory Considerations Expert Group provides guidance on a range of topics related to regulatory frameworks in clinical data management. This includes where to find applicable regulations, how to stay informed about new and emerging requirements, and which specific areas are relevant to data management, along with what they mean in practice. Find out more about their work here: https://acdmglobal.org/regulatory-considerations-dmeg/

Explore More News

Welcome ClinoSol Research as a new corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome ClinoSol . . .

CTU DMEG Update

The CTU DMEG has been actively discussing common problems that data managers face in . . .

ICH E8 (R1) General Considerations for Clinical Studies Impact on Data Management

The ACDM Regulatory Considerations have reviewed the Revision 1 to the ICH E8 Guidelines . . .

ACDM Comments on “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations; Draft Guidance for Industry, Investigators, and Other Stakeholders; Availability”

https://acdmglobal.org/wp-content/uploads/2022/04/ACDM_FDA_DHT.pdf

Have your say – MHRA’s public consultation on proposals for legislative changes for clinical trials

Dear Colleague, We have just launched our 8-week public consultation on proposals for . . .

Signant Health are ACDM22 Photography sponsors

The Association for Clinical Data Management are delighted to announce that Signant Health . . .

Anju Software is exhibiting at ACDM22

The Association for Clinical Data Management is delighted to announce that Anju Software . . .

SGS Health Science to sponsor ACDM Awards for the second year running

The Association for Clinical Data Management are delighted to announce that SGS Health . . .

ACDM Interactive

The ACDM would like to thank everyone involved with ACDM Interactive in Manchester. The . . .

nuvoteQ to be a Premier Sponsor of ACDM22

The Association for Clinical Data Management is delighted to announce that nuvoteQ are to . . .

IQVIA to be a Premier Sponsor of ACDM22

The Association for Clinical Data Management is delighted to announce that IQVIA are to be . . .

Anju Software to be a Premier Sponsor of ACDM22

The Association for Clinical Data Management is delighted to announce that Anju Software . . .